These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5854850)

  • 21. Unilateral pulmonary fibrosis and systemic sclerosis.
    Lesnyak VN; Danilevskaya OV; Averyanov AV; Ananyeva LP
    Am J Respir Crit Care Med; 2014 Nov; 190(9):1067-8. PubMed ID: 25360729
    [No Abstract]   [Full Text] [Related]  

  • 22. [An anatomo-clinical case of diffuse pulmonary fibrosis with chronic sclerodermic pulmonary heart].
    Plauchu M; Brune J; Rousset H; Loire R; Galy P
    Lyon Med; 1970 Dec; 224(41):817-23. PubMed ID: 5485438
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of leukotrienes in alveolitis associated with scleroderma.
    Simms RW; Korn JH
    Arthritis Rheum; 2003 Jun; 48(6):1478-80. PubMed ID: 12794812
    [No Abstract]   [Full Text] [Related]  

  • 24. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma.
    Wusirika R; Ferri C; Marin M; Knight DA; Waldman WJ; Ross P; Magro CM
    Am J Clin Pathol; 2003 Oct; 120(4):596-606. PubMed ID: 14560571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary arterial hypertension and generalized scleroderma. A propos of 10 cases].
    Commeau P; Grollier G; Foucaúlt JP; Potier JC
    Poumon Coeur; 1983; 39(1):31-5. PubMed ID: 6866890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute diffuse interstitial pulmonary fibrosis in scleroderma.
    READ J; COLEBATCH HJ; SMITH KV
    Australas Ann Med; 1960 Nov; 9():271-5. PubMed ID: 13740056
    [No Abstract]   [Full Text] [Related]  

  • 28. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
    McGonagle D; Tan AL; Madden J; Rawstron AC; Rehman A; Emery P; Thomas S
    Rheumatology (Oxford); 2008 Apr; 47(4):552-3. PubMed ID: 18281368
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pulmonary changes in progressive diffuse scleroderma].
    Schulz G
    Z Erkr Atmungsorgane Folia Bronchol; 1973 Feb; 137(2):175-86. PubMed ID: 4488893
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary fibrosis in scleroderma: report of a case with pulmonary function studies to evaluate corticosteroid and relaxin therapy.
    TRANQUADA RE; SIMMONS DH; MILLER JH
    Arch Intern Med; 1960 Apr; 105():607-12. PubMed ID: 13839183
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiac manifestations of diffuse systemic scleroderma. Apropos of 4 cases].
    Bennis A; Soulami S; Azzouzi L; Tahiri A; Chraibi N
    Ann Cardiol Angeiol (Paris); 1995 Mar; 44(3):119-24. PubMed ID: 7793849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The lung in connectivitis].
    Schettini A; Iones F; D'Andrea A; Pucino A; Vatrella A; Marsico SA
    Arch Monaldi; 1984; 39(1-2):3-26. PubMed ID: 6398036
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sclerodermic pneumofibrosis (clinical-functional characteristics)].
    Guseva NG; Falomeeva OM; Sysoev VF; Mach ES
    Ter Arkh; 1969 Mar; 41(3):36-41. PubMed ID: 5358782
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic sclerosis sine scleroderma presenting with vitiligo-like depigmentation and interstitial pulmonary fibrosis.
    De Villiers WJ; Jordaan HF; Bates W
    Clin Exp Dermatol; 1992 Mar; 17(2):127-31. PubMed ID: 1516238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
    Rottoli P; Magi B; Cianti R; Bargagli E; Vagaggini C; Nikiforakis N; Pallini V; Bini L
    Proteomics; 2005 Jul; 5(10):2612-8. PubMed ID: 15924291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Scleroderma and changes in the lungs].
    Stanojević B; Pavlović Z; Grncarević L; Tomić IM
    Plucne Bolesti Tuberk; 1974; 26(1):79-85. PubMed ID: 4410827
    [No Abstract]   [Full Text] [Related]  

  • 39. [Scleroderma and alveolar inflammation].
    Crestani B; Aubier M
    Rev Mal Respir; 1996; 13(1):15-20. PubMed ID: 8650411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of pulmonary function of idiopathic interstitial pneumonia--pulmonary diffusing capacity and small airway dynamics].
    Saito G
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Sep; 22(9):742-50. PubMed ID: 6521087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.